Parallax Volatility Advisers’s Ionis Pharmaceuticals IONS Stock Holding History

Parallax Volatility Advisers’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-200	Closed	-$6K	–	2929
2021 Q4	$6K	Hold	200	–	–	﹤0.01%	1945
2021 Q3	$7K	Buy	+200	New	+$7.54K	﹤0.01%	1917
2019 Q3	–	Sell	-25,000	Closed	-$1.61M	–	2884
2019 Q2	$1.61M	Sell	25,000 -134,800	-84%	-$9.53M	﹤0.01%	1114
2019 Q1	$13M	Buy	+159,800	New	+$10.3M	0.01%	409
2018 Q4	–	Sell	-35,000	Closed	-$1.8M	–	3409
2018 Q3	$1.8M	Buy	35,000 +15,000	+75%	+$705K	﹤0.01%	1055
2018 Q2	$833K	Buy	+20,000	New	+$887K	﹤0.01%	1144
2015 Q3	–	Sell	-44,600	Closed	-$2.57M	–	3477
2015 Q2	$2.57M	Buy	+44,600	New	+$2.84M	0.01%	980

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

Parallax Volatility Advisers's IONS Position: Q3 2024 in Review

Parallax Volatility Advisers sold out of Ionis Pharmaceuticals (IONS) in Q3 2024, closing a stake of 12,310 shares — an estimated $573K sold.

Parallax Volatility Advisers first reported a position in IONS in Q2 2015 and held it in 6 quarters. The position peaked at $1.11M in Q2 2015. 353 funds tracked by Wall St. Rank hold IONS as of Q3 2024.

Parallax Volatility Advisers reported no remaining Ionis Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Parallax Volatility Advisers sold 12,310 Ionis Pharmaceuticals shares in Q3 2024, an estimated $573K.
Parallax Volatility Advisers first reported a position in Ionis Pharmaceuticals in Q2 2015 and held it in 6 quarters.
Parallax Volatility Advisers's Ionis Pharmaceuticals position peaked at $1.11M in Q2 2015.
353 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2024.

Based on Parallax Volatility Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.